Back to Search
OMAR KHAN, DO
DO
Student in an Organized Health Care Education/Training Program
NPI: 1386493369Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
5151016589(MI)
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
What can be learned from open direct comparative trials in multiple sclerosis?
PMID 19200861·J Neurol Sci·2009
6-review
Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
PMID 18304034·J Neuroimaging·2008
8-other
Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
PMID 17548572·Neurology·2007
6-review
Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland.
PMID 16254014·Mol Endocrinol·2006
7-preclinical
Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis.
PMID 16320723·Mult Scler·2005
3-trial
Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.
PMID 12096936·CNS Drugs·2002
6-review
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapy.
PMID 11795454·Mult Scler·2001
3-trial
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis.
PMID 11284992·Eur J Neurol·2001
3-trial
Family with migraine and idiopathic bilateral striopallidodentate calcinosis.
PMID 19614694·Cephalalgia·2010
5-case
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
PMID 19528523·Neurology·2009
8-other
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
PMID 19255407·Neurology·2009
3-trial
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
PMID 19433659·Arch Neurol·2009
4-observational
Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.
PMID 19204159·Arch Neurol·2009
4-observational
Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging.
PMID 19243035·J Magn Reson Imaging·2009
8-other
Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis.
PMID 19111881·Cancer Cell·2009
7-preclinical
Isolation and identification of highly pathogenic avian influenza H5N1 virus from Houbara bustards (Chlamydotis undulata macqueenii) and contact falcons.
PMID 19130352·Avian Pathol·2009
7-preclinical
Pediatric-onset multiple sclerosis in African-American black and European-origin white patients.
PMID 19068251·Pediatr Neurol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 HARRINGTON ST
MOUNT CLEMENS, MI 48043 - Phone
- (586) 493-3727
Quick Facts
- NPI
- 1386493369
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile